| Primary Device ID | 10190302005173 |
| NIH Device Record Key | f1fc2f38-2985-4044-9037-d57417b02d0b |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | OpTmizer™ CTS™ T-Cell Expansion Supplement |
| Version Model Number | A1048402 |
| Company DUNS | 118793157 |
| Company Name | LIFE TECHNOLOGIES CORPORATION |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | false |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | false |
| Device Combination Product | false |
| Single Use | false |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 10190302005173 [Primary] |
| NDS | MEDIA, CULTURE, EX VIVO, TISSUE AND CELL |
| Steralize Prior To Use | false |
| Device Is Sterile | true |
| Public Version Status | Update |
| Device Record Status | Published |
| Public Version Number | 5 |
| Public Version Date | 2019-04-24 |
| Device Publish Date | 2016-08-01 |
| 10190302018982 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Assay | 2025-02-25 Component 1 of 4 of A56123 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
| 10190302018999 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Positive Control | 2025-02-25 Component 2 of 4 of A56123 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
| 10190302019002 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Negative Control | 2025-02-25 Component 3 of 4 of A56123 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
| 10190302019019 - TaqPath™ 1-Step Select Master Mix (No ROX) | 2025-02-25 Component 4 of 4 of A56123 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
| 10190302019026 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Assay | 2025-02-25 Component 1 of 4 of A56124 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
| 10190302019033 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Positive Control | 2025-02-25 Component 2 of 4 of A56124 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
| 10190302019040 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Negative Control | 2025-02-25 Component 3 of 4 of A56124 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
| 10190302019057 - TaqPath™ 1-Step Select Master Mix (No ROX) | 2025-02-25 Component 4 of 4 of A56124 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() OPTMIZER 98689540 not registered Live/Pending |
Life Technologies Corporation 2024-08-08 |
![]() OPTMIZER 97529880 not registered Live/Pending |
Wuwei Qingmeng Electronic Commerce Co.,Ltd. 2022-08-01 |